MENA healthcare market forecast to reach $412 billion by 2032 as Gulf states accelerate spending

The Middle East and North Africa healthcare market is projected to reach $412 billion by 2032, according to Economy Middle East.

The figure reflects rising public and private spending on hospital capacity, digital health systems, and insurance coverage across the region. The UAE and Saudi Arabia account for the largest share of regional healthcare expenditure, and both governments have made the sector central to their economic diversification plans.

What is behind the number

The UAE's population passed 10 million in recent years, and the federal government has expanded mandatory health insurance to all seven emirates under MOHAP oversight. DHA reported over 18 million outpatient visits in 2024, and Dubai continues to draw medical tourism patients from South Asia, Africa, and the CIS countries.

Saudi Arabia's Vision 2030 has committed large capital allocations to healthcare transformation, including the corporatisation of government hospitals and the creation of health clusters to attract private investment. The kingdom's healthcare market alone is expected to exceed $100 billion within the decade.

Across the wider MENA region, ageing demographics in North Africa, rising chronic disease rates, and post-pandemic preparedness investment are compounding demand. Diabetes affects roughly one in five adults in several Gulf states, among the highest rates globally, and it feeds sustained need for primary care, endocrinology, and dialysis services.

Where UAE operators should pay attention

For UAE-based healthcare organisations, the $412 billion regional figure has concrete operational implications. DOH in Abu Dhabi has tightened quality benchmarks and expanded scope-of-practice regulations for allied health professionals. DHA now requires electronic health record interoperability across all licensed facilities in Dubai.

The investment pipeline remains active. Pure Health, the UAE's largest integrated healthcare platform, has expanded through acquisitions. Burjeel Holdings continues to build out its network after its 2022 IPO on the Abu Dhabi Securities Exchange. Private equity interest in Gulf healthcare assets is strong, with mid-market clinic chains and diagnostics companies attracting premium valuations.

Health tech is taking a larger share of capital. Telemedicine platforms, AI-assisted diagnostics, and revenue cycle management software all saw increased adoption in 2024. MOHAP's updated telemedicine licensing framework, revised that year, gave virtual care operators a clearer regulatory path across emirate boundaries.

What to watch

The $412 billion projection assumes continued government spending and population growth. A slowdown in oil revenue or shifts in expatriate workforce policy could weaken the trajectory. Insurance reimbursement rate compression, already a concern for hospital operators in Dubai, could squeeze margins even as total market size grows.

CFOs and strategy leads at UAE healthcare organisations should track four signals:

• The pace of mandatory insurance expansion in the Northern Emirates
• DHA and DOH facility licensing volumes as a proxy for competitive intensity
• Cross-border patient flow data that shows whether the UAE is gaining or losing medical tourism share to Saudi Arabia's new mega-hospital projects
• Reimbursement rate trends from major insurers, which will determine whether revenue keeps pace with volume growth

The regional market is getting bigger. The question for UAE operators is whether their share of it grows too.